Scientific Review: CCCA Critique – Thomas COVID-19 Vaccines 6 months NEJM
We present several concerns regarding the recent article by Thomas et al. (2) on the efficacy and safety of the BNT162b2 mRNA coronavirus disease (COVID-19)
We present several concerns regarding the recent article by Thomas et al. (2) on the efficacy and safety of the BNT162b2 mRNA coronavirus disease (COVID-19)
ENTER YOUR SEARCH TERMS AND HIT ENTER